Tokyo Tape
Sign in
← Euglena

Quarterly report · Q2

2931.TEDINET S100RO90
Period2023-01-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥22.8bn2023-01-01 → 2023-06-30Cons.Net sales
Revenue¥44.4bn2022-01-01 → 2022-12-31Cons.Net sales (5-year summary)
Revenue¥21.6bn2022-01-01 → 2022-06-30Cons.Net sales
Operating income−¥760m2023-01-01 → 2023-06-30Cons.Operating income
Operating income−¥1.4bn2022-01-01 → 2022-06-30Cons.Operating income
Ordinary income−¥639m2023-01-01 → 2023-06-30Cons.Ordinary income
Ordinary income−¥2.5bn2022-01-01 → 2022-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥597m2022-01-01 → 2022-06-30Cons.Ordinary income
Profit before tax−¥618m2023-01-01 → 2023-06-30Cons.Income before income taxes
Profit before tax−¥595m2022-01-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)−¥914m2023-01-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥2.7bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥465m2022-01-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income−¥913m2023-01-01 → 2023-06-30Cons.Profit loss
Net income−¥462m2022-01-01 → 2022-06-30Cons.Profit loss
Total assets¥60.8bnat 2023-06-30Cons.Assets
Total assets¥57.3bnat 2022-12-31Cons.Assets
Total assets¥58.6bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥39.1bnat 2023-06-30Cons.Liabilities
Total liabilities¥37.9bnat 2022-12-31Cons.Liabilities
Net assets / equity¥21.7bnat 2023-06-30Cons.Net assets
Net assets / equity¥19.4bnat 2022-12-31Cons.Net assets
Net assets / equity¥19.9bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥16.3bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥10.0bnat 2022-12-31Cons.Cash and deposits
Cash & equivalents¥16.2bnat 2023-06-30Cons.Cash and cash equivalents
Cash & equivalents¥9.8bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥9.3bnat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥9.8bnat 2021-12-31dCons.Cash and cash equivalents
Operating cash flow¥500m2023-01-01 → 2023-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥924m2022-01-01 → 2022-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.1bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥351m2023-01-01 → 2023-06-30Cons.Net cash provided by used in investment activities
Investing cash flow¥1.2bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥531m2022-01-01 → 2022-06-30Cons.Net cash provided by used in investment activities
Financing cash flow¥6.2bn2023-01-01 → 2023-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥3.0bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.1bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-7.882023-01-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-6.382023-04-01 → 2023-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-23.832022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-4.182022-01-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-4.542022-04-01 → 2022-06-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio35.7%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio33.0%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio33.1%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 26
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-06-30−¥862m
jpcrp040300-q2r_E27054-000Biofuel Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥901m
jpcrp040300-q2r_E27054-000Biofuel Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥901m
jpcrp040300-q2r_E27054-000Biofuel Businessreportable segmentsegment profit2023-01-01 → 2023-06-30−¥432m
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥20.5bn
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥20.5bn
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentsegment profit2023-01-01 → 2023-06-30¥724m
jpcrp040300-q2r_E27054-000Others Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥1.4bn
jpcrp040300-q2r_E27054-000Others Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥1.4bn
jpcrp040300-q2r_E27054-000Others Businessreportable segmentsegment profit2023-01-01 → 2023-06-30−¥189m
Total Of Reportable Segments And Otherssegment totalrevenue2023-01-01 → 2023-06-30¥22.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-01-01 → 2023-06-30¥22.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-01-01 → 2023-06-30¥101m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-06-30−¥810m
jpcrp040300-q2r_E27054-000Biofuel Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥63m
jpcrp040300-q2r_E27054-000Biofuel Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥63m
jpcrp040300-q2r_E27054-000Biofuel Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥376m
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥20.2bn
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥20.2bn
jpcrp040300-q2r_E27054-000Health Care Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥122m
jpcrp040300-q2r_E27054-000Others Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥1.3bn
jpcrp040300-q2r_E27054-000Others Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥1.3bn
jpcrp040300-q2r_E27054-000Others Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥113m
Total Of Reportable Segments And Otherssegment totalrevenue2022-01-01 → 2022-06-30¥21.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-01-01 → 2022-06-30¥21.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-01-01 → 2022-06-30−¥611m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 627
ItemContextValueUnit
Effect of exchange rate change on cash and cash equivalentsPrior1YTDDuration8000000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration0JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration-549000000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration6344000000JPY
Cash and cash equivalentsPrior2YearInstant9820000000JPY
Cash and cash equivalentsPrior1YearInstant9814000000JPY
Cash and cash equivalentsPrior1QuarterInstant9271000000JPY
Cash and cash equivalentsCurrentQuarterInstant16158000000JPY
Salaries and allowances sgaPrior1YTDDuration1398000000JPY
Salaries and allowances sgaCurrentYTDDuration1615000000JPY
Advertising expenses sgaPrior1YTDDuration5407000000JPY
Advertising expenses sgaCurrentYTDDuration5458000000JPY
Research and development expenses sgaPrior1YTDDuration729000000JPY
Research and development expenses sgaCurrentYTDDuration591000000JPY
Depreciation sgaPrior1YTDDuration957000000JPY
Depreciation sgaCurrentYTDDuration1098000000JPY
Direct salesPrior1YTDDuration_jpcrp040300-q2r_E27054-000HealthCareBusinessReportableSegmentsMember17320000000JPY
Direct salesPrior1YTDDuration_jpcrp040300-q2r_E27054-000BiofuelBusinessReportableSegmentsMember－JPY
Direct salesPrior1YTDDuration_jpcrp040300-q2r_E27054-000OthersBusinessReportableSegmentsMember－JPY
Direct salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember17320000000JPY
Direct salesPrior1YTDDuration_ReconcilingItemsMember－JPY
Direct salesPrior1YTDDuration17320000000JPY
DistributionPrior1YTDDuration_jpcrp040300-q2r_E27054-000HealthCareBusinessReportableSegmentsMember1882000000JPY
DistributionPrior1YTDDuration_jpcrp040300-q2r_E27054-000BiofuelBusinessReportableSegmentsMember－JPY
DistributionPrior1YTDDuration_jpcrp040300-q2r_E27054-000OthersBusinessReportableSegmentsMember－JPY
DistributionPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember1882000000JPY
DistributionPrior1YTDDuration_ReconcilingItemsMember－JPY
DistributionPrior1YTDDuration1882000000JPY
Original equipment manufacturing material overseasPrior1YTDDuration_jpcrp040300-q2r_E27054-000HealthCareBusinessReportableSegmentsMember629000000JPY
Original equipment manufacturing material overseasPrior1YTDDuration_jpcrp040300-q2r_E27054-000BiofuelBusinessReportableSegmentsMember－JPY
Original equipment manufacturing material overseasPrior1YTDDuration_jpcrp040300-q2r_E27054-000OthersBusinessReportableSegmentsMember－JPY
Original equipment manufacturing material overseasPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember629000000JPY
Original equipment manufacturing material overseasPrior1YTDDuration_ReconcilingItemsMember－JPY
Original equipment manufacturing material overseasPrior1YTDDuration629000000JPY
OthersPrior1YTDDuration_jpcrp040300-q2r_E27054-000HealthCareBusinessReportableSegmentsMember394000000JPY
OthersPrior1YTDDuration_jpcrp040300-q2r_E27054-000BiofuelBusinessReportableSegmentsMember63000000JPY
OthersPrior1YTDDuration_jpcrp040300-q2r_E27054-000OthersBusinessReportableSegmentsMember1292000000JPY
OthersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember1751000000JPY
OthersPrior1YTDDuration_ReconcilingItemsMember－JPY
OthersPrior1YTDDuration1751000000JPY
Revenue from contracts with customersPrior1YTDDuration_jpcrp040300-q2r_E27054-000HealthCareBusinessReportableSegmentsMember20227000000JPY
Revenue from contracts with customersPrior1YTDDuration_jpcrp040300-q2r_E27054-000BiofuelBusinessReportableSegmentsMember63000000JPY
Revenue from contracts with customersPrior1YTDDuration_jpcrp040300-q2r_E27054-000OthersBusinessReportableSegmentsMember1292000000JPY
Revenue from contracts with customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember21584000000JPY
Revenue from contracts with customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenue from contracts with customersPrior1YTDDuration21584000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E27054-000HealthCareBusinessReportableSegmentsMember20227000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E27054-000BiofuelBusinessReportableSegmentsMember63000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E27054-000OthersBusinessReportableSegmentsMember1292000000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember21584000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-12-31pass rounding
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-01-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass